Ares Systematic Credit Ltd

Position in NVAX — Novavax Inc

CIK 2135379 LONDON, X0

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$755,060

+$26,229 QoQ

Shares Held

80,155

-10.5% QoQ

Ownership

0.049%

of shares outstanding

% of Portfolio

1.52%

of 13F equity value

Holder Rank

#75

of 263 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ares Systematic Credit Ltd holds $1,191,129 across 3 Biotechnology names. NVAX ranks #1 (63.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVAX	Novavax Inc This page	80,155	$755,060
2	JAZZ	Jazz Pharmaceuticals plc	1,201	$289,404
3	LGND	Ligand Pharmaceuticals Inc	464	$146,665

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$755,060	80,155	-10.5%	Shares	Sole	2026-08-14
2026-03-31	$728,831	89,537	-20.3%	Shares	Sole	2026-05-15
2025-12-31	$755,240	112,387	—	Shares	Sole	2026-05-19
No filing history on record for this holder in this stock.